D'Orazio & Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$877K Sell
4,722
-182
-4% -$33.8K 0.12% 66
2025
Q1
$1.03M Buy
4,904
+247
+5% +$51.8K 0.16% 56
2024
Q4
$828K Buy
4,657
+24
+0.5% +$4.27K 0.12% 61
2024
Q3
$915K Buy
4,633
+42
+0.9% +$8.29K 0.13% 59
2024
Q2
$787K Buy
4,591
+2
+0% +$343 0.12% 61
2024
Q1
$836K Buy
4,589
+355
+8% +$64.6K 0.13% 59
2023
Q4
$656K Sell
4,234
-142
-3% -$22K 0.12% 63
2023
Q3
$652K Buy
4,376
+948
+28% +$141K 0.15% 58
2023
Q2
$462K Sell
3,428
-473
-12% -$63.7K 0.11% 68
2023
Q1
$622K Sell
3,901
-69
-2% -$11K 0.16% 50
2022
Q4
$642K Buy
3,970
+152
+4% +$24.6K 0.15% 53
2022
Q3
$512K Buy
3,818
+1,227
+47% +$165K 0.15% 55
2022
Q2
$397K Sell
2,591
-63
-2% -$9.65K 0.11% 67
2022
Q1
$430K Buy
2,654
+504
+23% +$81.7K 0.1% 58
2021
Q4
$291K Buy
2,150
+58
+3% +$7.85K 0.07% 77
2021
Q3
$226K Buy
2,092
+187
+10% +$20.2K 0.06% 82
2021
Q2
$215K Sell
1,905
-15
-0.8% -$1.69K 0.06% 80
2021
Q1
$208K Buy
1,920
+24
+1% +$2.6K 0.06% 77
2020
Q4
$203K Sell
1,896
-195
-9% -$20.9K 0.07% 72
2020
Q3
$183K Buy
2,091
+199
+11% +$17.4K 0.07% 74
2020
Q2
$186K Buy
1,892
+11
+0.6% +$1.08K 0.08% 65
2020
Q1
$143K Buy
1,881
+4
+0.2% +$304 0.07% 73
2019
Q4
$166K Buy
1,877
+5
+0.3% +$442 0.05% 81
2019
Q3
$142K Buy
1,872
+372
+25% +$28.2K 0.05% 82
2019
Q2
$109K Sell
1,500
-22
-1% -$1.6K 0.03% 97
2019
Q1
$123K Buy
+1,522
New +$123K 0.04% 89
2018
Q4
Sell
-198
Closed -$19K 298
2018
Q3
$19K Buy
198
+2
+1% +$192 0.01% 184
2018
Q2
$18K Buy
+196
New +$18K 0.01% 177
2015
Q4
Sell
-38
Closed -$2K 257
2015
Q3
$2K Buy
+38
New +$2K ﹤0.01% 271